ClinicalTrials.Veeva

Menu

Almonds to Improve Gut Health and Decrease Inflammation

Oregon State University (OSU) logo

Oregon State University (OSU)

Status

Active, not recruiting

Conditions

Dysbiosis
Inflammation
Metabolic Syndrome

Treatments

Other: Almond
Other: Crackers

Study type

Interventional

Funder types

Other

Identifiers

NCT05790564
LPI-2022-1435

Details and patient eligibility

About

Almonds are a good source of beneficial compounds. This study will investigate if eating almonds everyday for 12 weeks can affect gut health and inflammation in persons with metabolic syndrome. Investigators will measure changes in metabolism, heart health, and the levels of vitamins and other compounds from almonds.

Full description

Metabolic Syndrome (MetS) affects over a billion people world-wide. MetS progression and further health complications are driven by chronic inflammation. Major causes of inflammation in MetS are gut barrier breakdown and the absorption of harmful bacteria. What causes the gut barrier breakdown is not clear, but a poor diet, especially low micronutrient intakes like vitamin E, is implicated by propagating a vicious cycle that promotes oxidative stress, inflammation and further gut barrier damage. This study will assess the impact of daily consumption of 2 ounces of almonds for 12 weeks on gut health, markers of inflammation and cardiometabolic health, and micronutrient status in persons with MetS.

Enrollment

80 estimated patients

Sex

All

Ages

35 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 35-60 years
  • 3 or more of the following: hypertension (systolic BP 130-179 mmHg or diastolic BP 85-119 mmHg); hyperglycemia (fasting glucose 100-599 mg/dL); central obesity [waist circumference greater than 40.1 inches (M) or 34.6 inches (F); hypertriglyceridemia (150-499 mg/dL); low HDL [lower than 40 mg/dL (M) or 50 mg/dL (F)]
  • Willing to restrict consumption of nuts other than study nuts for 1 week prior to and throughout the study (13 weeks)
  • Willing to stop probiotic supplements one week prior to and during the study (13 weeks)
  • Willing to stop multivitamins and supplements containing vitamin E, magnesium, calcium, iron, zinc and copper one week prior to and during the study (13 weeks)
  • Willing to complete intake diaries during the study
  • Willing to maintain current eating patterns (no significant diet change during study)

Exclusion criteria

  • Weekly consumption of almonds, hazelnuts, peanuts and sunflower seeds combined greater than 2 servings (about 2 oz) in the past 3 months
  • Nut, wheat, or gluten allergy/intolerance
  • Regular use of vitamin E supplements
  • Consume more than 2 alcoholic drinks daily
  • Tobacco use, including e-cigarettes, or smoking of any substance (e.g. cannabis) in the past 3 months
  • Pregnancy, breastfeeding, or planning to become pregnant before completing the study
  • Vigorous exercise greater than 7 hours/week
  • History of cardiovascular disease, liver disease or cancer
  • Have had bariatric surgery (e.g. gastric bypass, gastric banding, sleeve gastrectomy, etc.), other gastrointestinal procedures (e.g. cholecystectomy), disorders (e.g. Crohn's disease, celiac disease, ulcerative colitis) or chronic diarrhea
  • Diagnosis of hemochromatosis
  • Chronic use (daily intake in past 30 days) of anti-inflammatory medication (steroid or NSAID)
  • Use of ezetimibe or orlistat
  • Use of oral antibiotic medication within the past month
  • Body Mass Index (BMI) <25.0 or >35.0 kg/m2
  • Regular use of multivitamin supplements in the past 3 months
  • Physician prescribed use of probiotic, vitamin E, magnesium, calcium, iron, zinc or copper supplements

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

80 participants in 2 patient groups, including a placebo group

Almonds
Active Comparator group
Description:
Daily consumption of 2 ounces of unsalted, dry roasted almonds for 12 weeks
Treatment:
Other: Almond
Crackers
Placebo Comparator group
Description:
Daily consumption of non-whole grain crackers for 12 weeks (caloric equivalent to 2 ounces of dry roasted almonds)
Treatment:
Other: Crackers

Trial contacts and locations

1

Loading...

Central trial contact

Laura Beaver, PhD; Sandra Uesugi, RN, BSN, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems